About Aqtual
Aqtual is a company based in San Francisco (United States) founded in 2017.. Aqtual has raised $47 million across 2 funding rounds from investors including Yu Galaxy, Manta Ray and Genoa Ventures. The company has 29 employees as of December 31, 2024. Aqtual offers products and services including RA Blood Test and Epigenetics Catalog. Aqtual operates in a competitive market with competitors including Evergreen Nephrology, Pathalys, AdaptX, Specialty Networks and Bial, among others.
- Headquarter San Francisco, United States
- Employees 29 as on 31 Dec, 2024
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Aqtual
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$47 M (USD)
in 2 rounds
-
Latest Funding Round
$31 M (USD), Series B
Jul 10, 2025
-
Investors
Yu Galaxy
& 4 more
-
Employee Count
29
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aqtual
Aqtual offers a comprehensive portfolio of products and services, including RA Blood Test and Epigenetics Catalog. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Guides therapy management for Rheumatoid Arthritis through biomarker identification.
Provides disease-specific targets from cell-free DNA for drug development.
Unlock access to complete
Funding Insights of Aqtual
Aqtual has successfully raised a total of $47M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $31 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $31.0M
-
First Round
First Round
(31 Oct 2023)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2025 | Amount | Series B - Aqtual | Valuation |
investors |
|
| Oct, 2023 | Amount | Series A - Aqtual | Valuation | Yu Galaxy , Manta Ray Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Aqtual
Aqtual has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Yu Galaxy, Manta Ray and Genoa Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are made in innovative founders by Yu Galaxy.
|
Founded Year | Domain | Location | |
|
Early-stage ventures are targeted for investment by this VC fund.
|
Founded Year | Domain | Location | |
|
Early-stage VC firm focused on life science startups
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Aqtual
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Aqtual
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aqtual Comparisons
Competitors of Aqtual
Aqtual operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evergreen Nephrology, Pathalys, AdaptX, Specialty Networks and Bial, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Chronic care management services for kidney diseases are provided.
|
|
| domain | founded_year | HQ Location |
Biotherapeutics for chronic kidney disease are developed and provided.
|
|
| domain | founded_year | HQ Location |
Clinical management solutions are provided for healthcare by AdaptX.
|
|
| domain | founded_year | HQ Location |
Specialty Networks is focused on supporting independent specialty healthcare providers.
|
|
| domain | founded_year | HQ Location |
Develops and commercializes pharmaceutical products through research and global distribution.
|
|
| domain | founded_year | HQ Location |
Chronic care management services are provided to patients.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Aqtual
When was Aqtual founded?
Aqtual was founded in 2017 and raised its 1st funding round 6 years after it was founded.
Where is Aqtual located?
Aqtual is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Is Aqtual a funded company?
Aqtual is a funded company, having raised a total of $47M across 2 funding rounds to date. The company's 1st funding round was a Series A of $16M, raised on Oct 31, 2023.
How many employees does Aqtual have?
As of Dec 31, 2024, the latest employee count at Aqtual is 29.
What does Aqtual do?
Aqtual was founded in 2017 and is headquartered in San Francisco, United States. Operations focus on the healthcare sector, where clinical product launching services are offered to support medical innovations. Chronic disease management solutions are developed to address ongoing patient needs, while diagnostic platform services enable efficient testing and analysis. The company serves providers and stakeholders in the diagnostic and therapeutic fields across the region.
Who are the top competitors of Aqtual?
Aqtual's top competitors include Evergreen Nephrology, Pathalys and AdaptX.
What products or services does Aqtual offer?
Aqtual offers RA Blood Test and Epigenetics Catalog.
Who are Aqtual's investors?
Aqtual has 5 investors. Key investors include Yu Galaxy, Manta Ray, Genoa Ventures, Bold Capital Partners, and BOLD Longevity Growth.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.